RecruitingNot ApplicableNCT05195034

Effect of Dexmedetomidine on Postoperative Delirium After Awake Craniotomies

Effect of Dexmedetomidine on Postoperative Delirium in Patients Undergoing Awake Craniotomies: a Randomized Controlled Trial

Sponsor

Beijing Tiantan Hospital

Enrollment

210 participants

Start Date

Mar 31, 2022

Study Type

INTERVENTIONAL

Conditions

Dexmedetomidine Delirium Awake Craniotomy

Summary

Postoperative delirium (POD) is a common complication, and the incidence of POD ranges from 10% to 60%. Previous studies suggested that frontal approach and tumor located at the temporal lobe were independent risk factors for POD after supratentorial tumor resections. Therefore, patients undergoing awake craniotomies are high-risk populations for POD. A lot of trials show that dexmedetomidine might help to reduce the incidence of delirium in patients undergoing non-cardiac surgery. However, the impact of dexmedetomidine (DEX) on POD for patients undergoing awake craniotomies remains unclear. The purpose of this study was to investigate the effect of DEX on POD in patients undergoing awake craniotomies.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Patients undergoing selective awake craniotomies.
Age ≥18 years.
Obtain written informed consent.

Exclusion Criteria7

Preoperative moderate and severe cognitive impairment (Montreal Cognitive Assessment, MoCA\< 18).
Preoperative psychotropic medication within one year.
BMI≤18 or ≥30 Kg/ m2
Pregnant or lactating women.
History of traumatic brain injury or neurosurgery.
Severe bradycardia (heart rate less than 40 beats per minute), sick sinus syndrome or second-to-third degree atrioventricular block.
Severe hepatic or renal dysfunction.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexmedetomidine

The 200ug dexmedetomidine will be diluted into a 50ml syringe and administered with continuous infusion at a rate of 0.2 µg/kg/hour until the end of dural closure.

DRUG0.9% saline

The 0.9% saline is administered with the same volume at the same speed as the other group.